Question-and-Answer Session
Operator
Thank you ladies and gentlemen we will now begin the question-and-answer session. If you are a shareholder of Bard or a securities analyst (Operator Instructions). And our first question will come from the line of Seth Banerjee with Deutsche Bank. Please go ahead.
Seth Banerjee – Deutsche Bank
Hi guys, thank you for taking the question. Just first I wanted to just talk in general on pricing its going to common seamless quarter in mid tech and Todd you mention that volumes in the back half of the year going to impact the gross margin but can you provide any color on pricing this past quarter and you've seen overtime I mean I realize in the past that Bard has been pretty impermeable to pricing pressures but any color with that?
Todd C. Schermerhorn
No change, as really and obviously we look at on a same store same SKU basis and on a same SKU basis we are just not seen price now arguably its more difficult to up sell technology new features and so on, and so on a composite basis you might see a mix difference in our sales we are not get in the new mix but on a same SKU basis we are just seen in and we are looking hard for it. In terms of the comment on GP its just in our 6% constant currency growth we were budget it at 6% constant currency growth in our plants. So that’s a lower level of volume and the inventories trying to little bit in the middle of the year and I am going to have to adjust it into the fourth quarter here.
Seth Banerjee – Deutsche Bank
That’s helpful. Also on the horniest side I mean you did well in fixation and in natural tissue I just trying to understand why the synthetic business is lagging the market grows a bit, have you seen some of the accounts that had maybe moved to elsewhere have you seen them start to move back towards – synthetic or are they were locked in and waiting for next generation products.
Todd C. Schermerhorn
I think we've seen some of that with the Ventrio line of products that we launched in the Ventrio space but we were been without the new products and waiting for these new products in the – space that both John DeFord and I commented on late Bardex plug in late 3DMax. So it really is much like anything else it’s a pipeline issue and we'd like what we see coming in the pipeline both in our Q4 launches and also what we have in our pipeline for next year.
- To read the full transcript on Seeking Alpha, click here »
